期刊文献+

复发性卵巢癌的治疗现状 被引量:2

Progress on therapy of recurrent ovarian cancer
下载PDF
导出
摘要 目的卵巢癌死亡率高、易复发,其治疗目的是姑息和暂时缓解,而非得到根本治愈。方法复发性卵巢癌治疗方法主要包括手术和化疗,基因治疗和免疫治疗等。结果姑息性治疗是复发性卵巢癌治疗原则,以其达到延长患者生命、提高生活质量的目的。结论治疗技术日益更新以及治疗方法不断规范,将为患者带来新的希望。 Objective Ovarian cancer has the characteristic of high mortality rate and easy to recurrence.Therefore,the aim of ovarian cancer therapy is not to cure,but to get appeasement and temporarily ease of symptoms.Methods Therapy of recurrent ovarian cancer gives priority to surgery and chemotherapy,and biological therapies such as gene therapy and immunity therapy are becoming hotsot.Results The principle of recurrent ovarian cancer therapy is still a palliative treatment,prolonging patients' survival,and improving their life quality.Conclusion As the treatment means constantly update and therapy is becoming more standardized,which will bring new hope for patients of recurrent ovarian cancer.
作者 江莉 谢丰丽
出处 《中外医疗》 2012年第29期13-14,共2页 China & Foreign Medical Treatment
关键词 复发性卵巢癌 二次肿瘤细胞减灭术 化学疗法 基因治疗 免疫治疗 Recurrent ovarian cancer Secondary cytoreductive surgery Chemotherapy Gene therapy Immunity therapy
  • 相关文献

参考文献9

二级参考文献74

  • 1杨文兰,崔恒,冯捷,昌晓红,付天云,叶雪,张虹,李小平,温宏武,冯立民,童春容.卵巢癌抗独特型微抗体刺激树突细胞激活的T细胞对自体卵巢癌细胞杀伤作用的研究[J].癌症,2004,23(12):1639-1645. 被引量:3
  • 2赵彦,钱和年,回允中.卵巢癌患者单克隆抗体放射免疫显像对生存率的影响[J].中华妇产科杂志,1995,30(5):276-279. 被引量:4
  • 3刘琦,吴波,姜少军,孟奎,石群立,施正良.全反式维甲酸对卵巢上皮性癌荷瘤鼠干预后肿瘤细胞的超微结构变化[J].电子显微学报,2005,24(6):584-589. 被引量:11
  • 4曹泽毅,于莎莎.妇科恶性肿瘤治疗后一年内未控与复发原因的研究——附全国61所医院1753例分析[J].中华妇产科杂志,1996,31(7):417-421. 被引量:21
  • 5Burger RA, Sill MW, Monk B J, et al. Phase Ⅱ trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group study[ J ]. J Clin Oncol, 2007,25: 5165-5171.
  • 6Markman M, Liu PY, Wilczynski S, et al. Phase Ⅲ randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial[J]. J Clin Oncol, 2003, 21 : 2460-2465.
  • 7Pfisterer J, Plante M, Vergote I, et al. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an Intergroup Trial of the AGOOVAR, the NCIC CTG, and the EORTC GCG[J]. J Clin Oncol, 2006,6:913-918.
  • 8Sorbe B. Swedish-Norwegian Ovarian Cancer Study Group: consolidation treatment of advanced (FIGO) stage ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy,chmotherapy, and no further treatment [J ]. Int J Gynecol Cancer, 2003,13 ( 3 ) : 278 -286.
  • 9Thomas GM. Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer? [ J ]. Gynecol Oncol, 1993,51:97-103.
  • 10Tang H J, Jin X, Wang S, et al. A small molecule compound inhibits AKT pathway in ovarian cancer cell lines[J]. Gynecol Oncol,2006,100(2) :308-317.

共引文献105

同被引文献7

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部